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Purpose: To report the clinical and molecular features of a distinct form of transforming growth factor-β-induced
(TGFBI) gene-linked corneal dystrophy exhibiting a new granular corneal dystrophy type I (CDGG1) phenotype.
Methods: A complete ophthalmologic examination was performed in all individuals of a Chinese family in which
autosomal dominant transmission of the disease had been observed. DNA was obtained from the peripheral blood
leukocytes of each participating subject. Genetic analyses included keratin 3 (KRT3), keratin 12 (KRT12), and TGFBI
polymerase chain reaction (PCR) amplification and automated nucleotide sequencing of exons from the genomic DNA.
Results: The corneal phenotype in this pedigree was characterized by multiple bilateral dot-like, circular opacities at
different corneal depths, with some of the affected individuals only having opacities in the epithelium, which is different
from the typical CDGG1 phenotype. TGFBI analysis revealed a heterozygous point mutation at exon 12 (c.1663C>T) in
all of the affected individuals, predicting a p.R555W missense mutation.
Conclusions: The phenotype which resulted from the TGFBI R555W mutation in this family is distinct from that observed
in the typical case of CDGG1. We propose this disorder should be classified as a new phenotype of CDGG1, and this
finding demonstrates the importance of gene diagnosis in the corneal dystrophies.
The  corneal  dystrophies  (CDs)  are  genetically
determined diseases in which the progressive opacification of
the corneal layers results in a variable loss of transparency and
eventually in visual impairment [1]. Clinically, the corneal
dystrophies can be divided into three groups based on the sole
or predominant anatomic location of the abnormalities. Some
affect  primarily  the  corneal  epithelium  and  its  basement
membrane  or  Bowman  layer  and  the  superficial  corneal
stroma  (anterior  corneal  dystrophies),  the  corneal  stroma
(stromal corneal dystrophies), or the Descemet's membrane
and the corneal endothelium (posterior corneal dystrophies)
[2].
Sometime it is difficult to the clinical classification of a
special case. Since overlapping mutations can induce very
similar phenotypes, it is easy to appreciate the difficulty in
trying to distinguish them clinically. Therefore, molecular
genetic studies have come to have an important role in the
diagnosis of CDs, and the majority of CDs recognized to date
are  transmitted  in  an  autosomal  dominant  mode  of
transmission  with  a  high  degree  of  penetrance  [3].  An
apparent genotype–phenotype correlation has emerged from
these  molecular  studies,  as  four  distinct  heterozygous
recurrent  mutations  in  the  transforming  growth  factor-β-
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induced  gene  (TGFBI)  are  associated  with  four  specific
phenotypes: p.R555W in granular corneal dystrophy type I
(CDGG1), p.R124C in Lattice CD type I, p.R124H in granular
CD (GCD) type II, and p.R555Q in Thiel-Behnke CD [3-5].
Corneal granular dystrophies are a group of disorders
which were originally described by Groenouw [6] and are
some of the most common corneal dystrophies seen in clinical
practice  [7].  The  most  typical  kind  of  corneal  granular
dystrophy,  CDGG1  (OMIM  121900),  is  characterized  by
small, discrete, sharply demarcated grayish white opacities
resembling bread crumbs or snowflakes in the anterior central
stroma.  The  histological  findings  are  typically  hyaline
degeneration  and  absence  of  acid  mucopoly-saccharide
depositions.
This  atypical  corneal  dystrophy  in  a  Chinese  six-
generation  family  which  was  identified  using  molecular
genetic studies, is proposed as a new phenotype of CDGG1,
and confirms the relationship between CDGG1 and p.R555W
in the TGFBI gene.
METHODS
Family data and genomic DNA preparation: A six-generation
family with atypical corneal dystrophy was identified through
the Eye Center of the 2nd Affiliated Hospital, Medical College
of  Zhejiang  University,  Hangzhou,  China.  Appropriate
informed consent was obtained from all participants and the
study protocol followed the principles of the Declaration of
Helsinki.  Thirty-eight  individuals  (14  affected  and  24
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225unaffected) from the family took part in the study (Figure 1).
The  affected  status  was  determined  by  ophthalmologic
examination, including visual acuity, slit lamp, and fundus
examination. The phenotypes were documented by slit lamp
photography.
Genomic DNA preparation: We collected blood specimens
(5 ml) in EDTA and extracted genomic DNA in the peripheral
blood leukocytes obtained from the available family members
using a Simgen Blood DNA mini kit (Simgen, Hangzhou,
China).
Mutation  screening:  Gene  specific  PCR  primers  for
keratin  3  (KRT3),  keratin  12  (KRT12),  and  TGFBI  were
designed which flanked each exon and intron-exon junction
(PCR primers for TGFBI are shown in Table 1). The PCR
cycling conditions were as follows: 95 °C preactivation for 5
min, 10 cycles of touchdown PCR with a 1 °C reduction per
cycle  from  60  °C  to  50  °C,  followed  by  25  cycles  with
denaturation at 95 °C for 25 s, annealing at 55 °C for 25 s, and
extension at 72 °C for 40 s and a final extension at 72 °C for
10 min. PCR products were isolated by electrophoresis on
1.5%  agarose  gels  and  sequenced  using  the  BigDye
Terminator  Cycle  sequencing  kit  V  3.1  (ABI  Applied
Biosystems;  Genscript  Co.,  Nanjing,  China)  on  an  ABI
PRISM  3730  Sequence  Analyzer  (ABI),  according  to  the
manufacturer’s instructions.
RESULTS
Clinical  evaluation:  The  six-generation  Chinese  family
displayed the hallmarks of autosomal dominant inheritance
(Figure 1). To confirm the clinical diagnosis, all individuals
from whom DNA had been obtained underwent slit lamp
examination. The characteristic lesions in the cornea are dot-
like  or  round,  discrete,  sharply  demarcated  grayish  white
opacities, and are found mainly in the central region. The
appearance of the lesions was almost the same as typical
CDGG1, but of the lesion depths were distinctly different.
Furthermore, the lesion depths were found to be different
between the affected individuals (Figure 2).The proband and
another five members had corneal opacities in epithelium and
anterior stroma bilaterally, but four out of fourteen members
had opacities only in the epithelium, while four other members
had opacities deeper than the middle stroma (Table 2). Most
of the affected individuals noticed visual impairment after
approximately the age of ten, and then their visual acuity
decreased gradually with occasional photophobia. There was
no family history of other ocular or systemic abnormalities
aside from age-related disorders.
Mutation screening: Bidirectional sequencing of the coding
regions  of  the  candidate  genes  revealed  the  heterozygous
change of C>T at position 1663 (c.1663 C>T) of TGFBI in
each of the three affected individuals. This substitution was
not seen in the unaffected members or in 100 unrelated control
subjects  from  the  same  Chinese  population,  as  tested  by
bidirectional sequence analysis (Figure 3). This substitution
results in the replacement of a highly conserved Arginine by
Tryptophan at amino acid position 555 (p.R555W) in the
fourth internal domain of TGFBIp (The protein encoded by
TGFBI).
DISCUSSION
The proband reported here had grayish-whie dot-like circular
opacities with some erosive lesions in the epithelium and only
a few opacities in the anterior stroma. Therefore, the first
clinical  impression  is  of  a  kind  of  anterior  CD  primarily
affecting the corneal epithelium and its basement membrane
or Bowman layer and the superficial corneal stroma. The
mutations reported in the cases of the anterior CDs include the
keratin genes KRT3 on chromosome 12q13 and KRT12 on
chromosome  17q12  [8-10],  and  the  TGFBI  gene  on
chromosome 5q31, which is linked to both Reis-Bücklers and
Thiel-Behnke dystrophies [5,7]. Thiel–Behnke is also linked
to a mutation on chromosome 10q23–24, although the gene
product is currently unknown [11].
We use the functional candidate gene analysis approach,
and  sequenced  the  PCR  product  of  the  candidate  genes
KRT3, KRT12, and TGFBI. Instead of finding the mutation
site previously reported to be related to the anterior CDs, we
Figure 1. Pedigree demonstrating the six generations of affected members in a Chinese family having a p.R555W mutation in the TGFBI gene.
The filled symbols represent the affected individuals. *=Individuals in whom molecular genetic investigation was performed. The arrow
indicates the proband.
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226found  a  mutation  site  (C.1663C>T)  in  TGFBI  causing  a
protein change (p.R555W) which has been reported to have a
definite relationship with CDGG1 [3-5].
It was found that out of the 14 affected members, 4 had
opacities only in the epithelium, 6 had opacities mainly in the
epithelium, and a few in the anterior stroma (just like the
proband), 2 had opacities in the epithelium and the anterior
and middle stroma, and 2 had opacities in the epithelium and
total  stroma  equivalent  to  the  typical  CDGG1  phenotype.
Most of the affected individuals noticed visual impairment
shortly  after  the  age  of  ten,  and  then  their  visual  acuity
decreased  gradually  with  occasional  photophobia.  The
decrease in visual acuity in the affected members were related
with increases of irregular astigmatism and was presumed to
be related to the opacities in the pupil area of cornea. All of
the affected family members have distance visual acuity better
than 20/80 without any need of corneal transplant, so it was
not possible to perform histological analysis.
A  precise  diagnosis  of  corneal  disorders  cannot  rely
solely on the clinical or histological features of the pathology.
Certain mutations in TGFBI appear to be associated with
specific phenotypes of corneal disease regardless of ethnic
group. Since the c.1663C>T (p.R555W) mutation in TGFBI
was first identified for CDGG1 by Munier et al. [12], this
mutation has been shown to have a clear genotype-phenotype
correlation with CDGG1 [3-5], and CDGG1 in association
with  the  p.  R555W  mutation  is  reported  to  be  the  most
prevalent  type  of  GCD  in  several  different  ethnic  groups
[13-16].  Therefore,  genetic  investigation  is  useful  in  the
diagnosis of CDGG1, especially the atypical cases. In this
study, we provide clinical and molecular evidence supporting
TABLE 1. PRIMERS USED IN POLYMERASE CHAIN REACTION OF THE TGFBI GENE.
Exon Primers Sequence Product size Reference
1 1F GCGCTCTCACTTCCCTGGAG 247 bp [8]
  1R GACTACCTGACCTTCCGCAG   [8]
2 2F GAGTCATTAAAGTGGGGTGGA 253 bp [8]
  2R CAACCTGACCTTCTAGAAGGCT   [8]
3 3F ACTTAGTGGAGAGGGGCCAGA 206 bp [9]
  3R TCCTCTCTCCCACCATTCCCTT   [9]
4 4F TCAGAGAAGGGAGGGTGTGGTT 292 bp [10]
  4R CCTCGGGGAAGTAAGGCAGTT   [10]
5 5F CAGAGTTGCAAGGACCCATCT 308 bp [10]
  5R AGCCCACACATGGAACAGAAATG   [9]
6 6F ACACTGTTTTCTCCTCCCGG 299 bp [10]
  6R AGAGTTCCTGCTAGGCCCCTCTT   [9]
7 7F TGTGCATCTTCTGTGGGGAGT 233 bp [10]
  7R AGAGCAGGTCTTGGGCTCAA   [10]
8 8F TGCAAGTGGTCCCTGAGGTTAT 343 bp [11]
  8R CACAAAGGATGGCAGAAGAGA   [12]
9 9F CCCTGGGGTGGATGAATGATAAA 285 bp [9]
  9R AGAGTGTTGTGGAGGTGACAG   [10]
10 10F TCACTTGGTTTCTCAATCCCTG 376 bp This study
  10R CTCATGCAAACTCCTGCTTATTG   This study
11 11F ACCCTGCTACATGCTCTGAAC 282 bp [10]
  11R CACATCCCACTCCAGCATGAC   [10]
12 12F TCTCAGCGTGGTGAGGTATT 257 bp [10]
  12R CCCTGAGGGATCACTACTTT   [13]
13 13F CCTCCTTGACCAGGCTAATTAC 255 bp [13]
  13R TGAGATATGTCCTGGAGCCCT   [11]
14 14F CTGTTCAGTAAACACTTGCTG 257 bp [13]
  14R CCACCAACTGCCACATGGAGAA   This study
15 15F CTCAGTCACGGTTGTTATGA 218 bp [12]
  15R TCTATGGCCCAAACAGAGGA   This study
16 16F CATTGTCATAAGCAGTTGCAG 174 bp [12]
  16R ATACAGCAGATGGCAGGCTT   [10]
17 17F TCCTAGACAGACATGGGGAGAT 426 bp This study
  17R TGAGAGAAATTGGCGGAGAG   This study
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227the occurrence of an atypical CDGG1 phenotype attributable
to the TGFBI p.R555W mutation.
The typical CDGG1 is characterized by grayish-white
granules in the anterior central stroma, and as the disease
advances, the number and extent of the opacities increase and
the epithelium is progressively involved. In the Classification
of Corneal Dystrophies III (IC3D),  CDGG1 is described in
children as a corneal disease with a vortex pattern of brownish
granules  superficial  to  Bowman's  layer  but  not  to  the
epithelium, and in later life, granules may extend into the
deeper stroma down to Descemet's membrane [17]. In contrast
with the former phenotype, we propose this Chinese CDGG1
case as a new phenotype which is characterized at first by first
grayish-white  granules  in  the  corneal  epithelium  and
subsequently by progression into the deeper stroma. The rate
of progression was different among the family members. For
most of the affected members, corneal lesions had developed
in the stroma after after the age of approximately ten, but one
40-year-old man still only has opacities in the epithelium,
indicating  phenotype  heterogeneity  in  this  family.
Environmental  factors  may  contribute  to  this  interfamily
variability in phenotypic expression. As some patients still
have as yet only mild clinical manifestations, regular clinical
follow-up will be performed.
The  protein  encoded  by  TGFBI  is  βig-h3  (TGFBIp,
Keratoepithelin), which consists of an NH2-terminal Cys-rich
EMI domain and four consecutive fasciclin 1 (FAS1) domains
[18]. The four FAS1 domains in human TGFBIp correspond
to amino acids 134–236 (FAS1–1), 242–372 (FAS1–2), 373–
501  (FAS1–3),  and  502–632  (FAS1–4).  The  p.R555W
mutation is located in the FAS1–4 region, and is predicted to
alter either protein solubility or stability rather than protein
structure [19]. Runager et al. [20] suggested a replacement by
a  hydrophobic  amino  acid  residue  (Trp)  rather  than  a
positively charged hydrophilic (Arg) in this position may be
likely to increase the propensity of the protein to associate,
potentially lowering the solubility, simply by reducing the
level of electrostatic repulsion. An increased level of intact
Figure 3. Sequence chromatogram from exon 12 of the TGFBI gene
showing the region around codon 555 to illustrate a heterozygous C
to T transition in the affected individuals. The sense strand is shown;
codon 555 is boxed.
Figure 2. Clinical photographs of patients with atypical CDGG1. A: A slit lamp photograph of the proband's cornea (Figure 1, V2) showing
multiple round and dot-like grayish white opacities in the central stroma. B: A slit lamp photograph of the proband's cornea showing the
opacities in the epithelium and anterior stroma. C: A slit lamp photograph of the cornea in patient IV6 (Figure 1, IV6) showing the opacities
in the epithelium and total stroma. D: A slit lamp photograph of the cornea in patient IV20 (Figure 1, IV20) showing opacities only in the
epithelium.
TABLE 2. DEPTH OF CORNEA LESIONS IN AFFECTED INDIVIDUALS.
Depth of cornea lesions Patient's number (age)
Epithelium IV11 (9Y), VI1 (7Y), IV20 (40Y), V14 (10Y)
Epithelium and anterior stroma III3 (70Y), IV9 (41Y), IV14 (34Y), V1 (29Y), V2 (28Y), V6 (23Y)
Epithelium, anterior and middle stroma IV1 (52Y), V9 (15Y)
Epithelium and total stroma IV6(46Y), IV11(41Y)
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228R555W TGFBIp has been observed in corneal deposits in
vivo,  supporting  that  the  mutant  protein  is  resistant  to
degradation  and  that  an  increase  in  protein  stability  may
indeed  have  pathological  consequences  [21].  Moreover,
Morand et al. [22] reported that the mutation p.R555W in
TGFBIp triggered apoptosis in human corneal epithelial cells,
and suggested that aberrant activation of the α3β1 integrin-
related  pathway  by  mutated  TGFBIp  is  part  of  the
pathophysiological process that leads to the TGFBI-related
CDs.
Previous studies which conducted immunohistochemical
and  biochemical  analyses  on  the  nature  of  the  abnormal
deposits  in  the  CDs  revealed  the  TGFBIp  to  be  a  major
component in all types of TGFBI-related CD [14,21,23]. The
deposits  have  been  precisely  localized  in  the  stroma  for
CDGG1 [5,18,24]. Based on our case, we suggest that the
deposits in CDGG1 can also first appear in the epithelium.
In summary, we report a Chinese CDGG1 pedigree with
an  atypical  phenotype  characterized  corneal  lesions  first
appearing  in  the  epithelium.  This  finding  expands  the
spectrum of the CDGG1 phenotypes caused by the p.R555W
mutation in the TGFBI gene, and demonstrates the importance
of gene diagnosis in the corneal dystrophies.
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